CREST-2 Findings Highlight Evolving Role of Carotid Artery Stenting - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

CREST-2 Findings Highlight Evolving Role of Carotid Artery Stenting

  • By

  • September 14, 2026

  • 5 min

Share

Clinical Scorecard: CREST-2 Findings Highlight Evolving Role of Carotid Artery Stenting

At a Glance

CategoryDetail
ConditionSevere Asymptomatic Carotid Stenosis
Key MechanismsCarotid artery stenting (CAS) combined with intensive medical management.
Target PopulationPatients with at least 70 percent asymptomatic carotid stenosis.
Care SettingNeurointerventional specialty care.

Key Highlights

  • CAS plus intensive medical management showed a primary outcome rate of 2.8% at four years.
  • Operator experience and careful patient selection are critical for favorable outcomes.
  • Standardized procedural techniques were employed in the trial.
  • Intensive medical therapy remains foundational in managing asymptomatic carotid stenosis.
  • The trial emphasizes the importance of individualized treatment pathways.

Guideline-Based Recommendations

Diagnosis

  • Assess carotid stenosis severity using imaging techniques.

Management

  • Consider CAS in selected patients with severe asymptomatic carotid stenosis.

Monitoring & Follow-up

  • Monitor patients for stroke risk and adjust medical therapy as needed.

Risks

  • Consider procedural risks associated with carotid stenting and patient anatomy.

Patient & Prescribing Data

Patients with severe asymptomatic carotid stenosis.

Intensive medical management should be combined with CAS for optimal outcomes.

Clinical Best Practices

  • Ensure operator experience and training in carotid stenting.
  • Utilize standardized techniques and protocols during procedures.
  • Conduct multidisciplinary assessments for treatment planning.

Related Resources & Content

Original Source(s)

Related Content